Effect of hyperbaric oxygen on mesenchymal stem cells for lumbar fusion in vivo
Hyperbaric oxygen (HBO) therapy has been proved in improving bone healing, but its effects on mesenchymal stem cells (MSCs) in vivo is not clear. The aims of this study are to clarify whether the HBO therapy has the same enhancing effect on MSCs with regard to bone formation and maturation and to ascertain whether the transplanted MSCs survive in the grafted area and contribute to new bone formation.
Methods: Twenty-three adult rabbits underwent posterolateral fusion at L4-L5 level.
The animals were divided into three groups according to the material implanted and subsequent treatment: (1) Alginate carrier (n=6); (2) Alginate-MSCs composite (n=11); and (3) Alginate-MSCs composite with HBO therapy (n=6). After 12 weeks, spine fusion was examined using radiographic examination, manual testing, and histological examination.
Using a PKH fluorescence labeling system, whether the transplanted MSCs survived and contributed to new bone formation in the grafted area after HBO therapy was also examined.
Results: The bilateral fusion areas in each animal were evaluated independently. By radiographic examination and manual palpation, union for the Alginate, Alginate-MSCs, and Alginate-MSCs-HBO groups was 0 of 12, 10 of 22, and 6 of 12 respectively.
The difference between the Alginate-MSCs and Alginate-MSCs-HBO groups was not significant (P=0.7997). The fluorescence microscopy histological analysis indicated that the transplanted PKH67-labeled MSCs survived and partly contributed to new bone formation in the grafted area.
Conclusions: This study demonstrated that the preconditioned MSCs could survive and yield bone formation in the grafted area.
HBO therapy did not enhance the osteogenic ability of MSCs and improve the success of spine fusion in the rabbit model. Although there was no significant effect of HBO therapy on MSCs for spine fusion, the study encourages us to research a more basic approach for determining the optimal oxygen tension and pressure that are required to maintain and enhance the osteogenic ability of preconditioned MSCs.
Further controlled in vivo and in vitro studies are required for achieving a better understanding of the effect of HBO treatment on MSCs.
Author: Tsai-Sheng FuSteve W. N. UengTsung-Ting TsaiLih-Huei ChenSong-Shu LinWen-Jer Chen
Credits/Source: BMC Musculoskeletal Disorders 2010, 11:52
Published on: 2010-03-19
Copyright by the authors listed above - made available via BioMedCentral (Open Access). Please
make sure to read our disclaimer prior to contacting 7thSpace Interactive. To contact our editors, visit our online helpdesk. If you wish submit your own press release, click here.
Social Bookmarking
RETWEET This! | Digg this! | Post to del.icio.us | Post to Furl | Add to Netscape | Add to Yahoo! | Rojo
|
|
